Detalhe da pesquisa
1.
Should we consider caplacizumab as routine treatment for acute thrombotic thrombocytopenic purpura? An expert perspective on the pros and cons.
Expert Rev Hematol
; 17(1-3): 9-25, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38353182
2.
Multicentric evaluation of the new HemosIL Acustar® chemiluminescence ADAMTS13 activity assay.
Int J Lab Hematol
; 43(3): 485-493, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33264480